A detailed history of Firestone Capital Management transactions in Abb Vie Inc. stock. As of the latest transaction made, Firestone Capital Management holds 1,585 shares of ABBV stock, worth $261,509. This represents 0.08% of its overall portfolio holdings.

Number of Shares
1,585
Previous 1,585 -0.0%
Holding current value
$261,509
Previous $271,000 15.5%
% of portfolio
0.08%
Previous 0.08%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 11, 2023

BUY
$144.61 - $166.54 $229,206 - $263,965
1,585 New
1,585 $252,000
Q4 2021

Feb 11, 2022

SELL
$107.43 - $135.93 $62,846 - $79,519
-585 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$72.13 - $90.25 $40,032 - $50,088
555 Added 1850.0%
585 $52,000
Q4 2019

Feb 10, 2020

BUY
$72.13 - $90.25 $2,163 - $2,707
30 New
30 $52,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $292B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Firestone Capital Management Portfolio

Follow Firestone Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Firestone Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Firestone Capital Management with notifications on news.